- Home
- Publications
- Publication Search
- Publication Details
Title
The Pharmacogenetics of Alcohol Use Disorder
Authors
Keywords
-
Journal
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
Volume 39, Issue 3, Pages 391-402
Publisher
Wiley
Online
2015-02-19
DOI
10.1111/acer.12643
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Associations ofOPRM1A118G and alcohol sensitivity with intravenous alcohol self-administration in young adults
- (2014) Christian S. Hendershot et al. ADDICTION BIOLOGY
- Interactive Effects of OPRM1 and DAT1 Genetic Variation on Subjective Responses to Alcohol
- (2014) Lara A. Ray et al. ALCOHOL AND ALCOHOLISM
- Topiramate Treatment for Heavy Drinkers: Moderation by aGRIK1Polymorphism
- (2014) Henry R. Kranzler et al. AMERICAN JOURNAL OF PSYCHIATRY
- ALDH2*2 but not ADH1B*2 is a causative variant gene allele for Asian alcohol flushing after a low-dose challenge
- (2014) Giia-Sheun Peng et al. Pharmacogenetics and Genomics
- Variation in AKR1C3, which encodes the neuroactive steroid synthetic enzyme 3α-HSD type 2 (17β-HSD type 5), moderates the subjective effects of alcohol
- (2014) Verica Milivojevic et al. PSYCHOPHARMACOLOGY
- Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate
- (2014) V M Karpyak et al. Translational Psychiatry
- A GABRA2 Variant Is Associated with Increased Stimulation and ‘High’ Following Alcohol Administration
- (2013) Albert J. Arias et al. ALCOHOL AND ALCOHOLISM
- Efficacy of Disulfiram for the Treatment of Alcohol Dependence Assessed with a Multicenter Randomized Controlled Trial
- (2013) Atsushi Yoshimura et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Determination of Genotype Combinations That Can Predict the Outcome of the Treatment of Alcohol Dependence Using the 5-HT3Antagonist Ondansetron
- (2013) Bankole A. Johnson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Genome-wide association study of alcohol dependence:significant findings in African- and European-Americans including novel risk loci
- (2013) J Gelernter et al. MOLECULAR PSYCHIATRY
- Candidate Gene Studies of a Promising Intermediate Phenotype: Failure to Replicate
- (2013) Amy B Hart et al. NEUROPSYCHOPHARMACOLOGY
- Association of Gamma-Aminobutyric Acid A Receptor α2 Gene (GABRA2) with Alcohol Use Disorder
- (2013) Dawei Li et al. NEUROPSYCHOPHARMACOLOGY
- GABRA2markers moderate the subjective effects of alcohol
- (2012) Magdalena Uhart et al. ADDICTION BIOLOGY
- Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis
- (2012) Antonio-Javier Chamorro et al. ADDICTION BIOLOGY
- Variation inOPRM1moderates the effect of desire to drink on subsequent drinking and its attenuation by naltrexone treatment
- (2012) Henry R. Kranzler et al. ADDICTION BIOLOGY
- Subjective Response to Alcohol Among Alcohol-Dependent Individuals: Effects of the Mu-Opioid Receptor (OPRM1) Gene and Alcoholism Severity
- (2012) Lara A. Ray et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Reduced Dopamine Receptor Sensitivity as an Intermediate Phenotype in Alcohol Dependence and the Role of the COMT Val158Met and DRD2 Taq1A Genotypes
- (2012) Barbara Franke ARCHIVES OF GENERAL PSYCHIATRY
- Pharmacogenetic Randomized Trial for Cocaine Abuse: Disulfiram and Dopamine β-Hydroxylase
- (2012) Thomas R. Kosten et al. BIOLOGICAL PSYCHIATRY
- The clinical pharmacology of acamprosate
- (2012) Nicola J. Kalk et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Understanding naltrexone mechanism of action and pharmacogenetics in Asian Americans via behavioral economics: A preliminary study.
- (2012) Spencer Bujarski et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- A large-scale meta-analysis of the association between the ANKK1/DRD2 Taq1A polymorphism and alcohol dependence
- (2012) Fan Wang et al. HUMAN GENETICS
- Genetic architectures of psychiatric disorders: the emerging picture and its implications
- (2012) Patrick F. Sullivan et al. NATURE REVIEWS GENETICS
- Interacting Effects of Naltrexone and OPRM1 and DAT1 Variation on the Neural Response to Alcohol Cues
- (2012) Joseph P Schacht et al. NEUROPSYCHOPHARMACOLOGY
- Ethnicity interacts with the OPRM1 gene in experimental pain sensitivity
- (2012) Barbara A. Hastie et al. PAIN
- Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol
- (2012) James R. Ashenhurst et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Personalized Treatment of Alcohol Dependence
- (2012) Henry R. Kranzler et al. Current Psychiatry Reports
- Variation in Genes Encoding the Neuroactive Steroid Synthetic Enzymes 5α-Reductase Type 1 and 3α-Reductase Type 2 Is Associated With Alcohol Dependence
- (2011) Verica Milivojevic et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- The Effect of Naltrexone on Alcohol’s Stimulant Properties and Self-Administration Behavior in Social Drinkers: Influence of Gender and Genotype
- (2011) Elaine Setiawan et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Pharmacogenetic Approach at the Serotonin Transporter Gene as a Method of Reducing the Severity of Alcohol Drinking
- (2011) Bankole A. Johnson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Pharmacogenetics of Naltrexone in Asian Americans: A Randomized Placebo-Controlled Laboratory Study
- (2011) Lara A Ray et al. NEUROPSYCHOPHARMACOLOGY
- Genetic and environmental influences on cannabis use initiation and problematic use: a meta-analysis of twin studies
- (2010) Karin J. H. Verweij et al. ADDICTION
- Interaction ofSLC6A4andDRD2polymorphisms is associated with a history of delirium tremens
- (2010) Victor M. Karpyak et al. ADDICTION BIOLOGY
- Role of GABRA2 in Moderating Subjective Responses to Alcohol
- (2010) Sungwon Roh et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Medication Treatment of Different Types of Alcoholism
- (2010) Bankole A. Johnson AMERICAN JOURNAL OF PSYCHIATRY
- Human behavioral pharmacology, past, present, and future: symposium presented at the 50th annual meeting of the Behavioral Pharmacology Society
- (2010) Sandra D. Comer et al. BEHAVIOURAL PHARMACOLOGY
- A Double-Blind, Randomized Trial of Sertraline for Alcohol Dependence
- (2010) Henry R. Kranzler et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- A population-based twin study of the genetic and environmental relationship of major depression, regular tobacco use and nicotine dependence
- (2010) A. C. Edwards et al. PSYCHOLOGICAL MEDICINE
- Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators
- (2009) Wendy Ooteman et al. ADDICTION BIOLOGY
- Association of Markers in the 3′ Region of the GluR5 Kainate Receptor Subunit Gene to Alcohol Dependence
- (2009) Henry R. Kranzler et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- A preliminary pharmacogenetic investigation of adverse events from topiramate in heavy drinkers.
- (2009) Lara A. Ray et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- Typologies of Alcohol Dependence. From Jellinek to Genetics and Beyond
- (2009) Lorenzo Leggio et al. NEUROPSYCHOLOGY REVIEW
- The Alcoholic Phenotypes among Different Multidimensional Typologies: Similarities and Their Classification Procedures
- (2008) S. Pombo et al. ALCOHOL AND ALCOHOLISM
- Effects of Opioid Receptor Gene Variation on Targeted Nalmefene Treatment in Heavy Drinkers
- (2008) Albert J. Arias et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- An Evaluation of μ-Opioid Receptor (OPRM1) as a Predictor of Naltrexone Response in the Treatment of Alcohol Dependence
- (2008) Raymond F. Anton et al. ARCHIVES OF GENERAL PSYCHIATRY
- A mu opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients
- (2008) Sung-Gon Kim et al. PSYCHOPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More